Author Archives: Natalie Themm
Myriad Genetics and Intermountain Health Participate in ComboMATCH, a National Clinical Trial to Advance Cancer Treatment
ComboMATCH study uses genetic testing to match advanced cancer patients with targeted treatments
Renalytix Clinical Advisory Board Formed to Support Broadening Use of KidneyintelX.dkd
World leading, multi-disciplinary experts advise on adoption of FDA authorized KidneyintelX.dkd across 14 million US patients with diabetes and chronic kidney disease
Merit Medical’s WRAPSODY™ Arteriovenous Access Efficacy (WAVE) Pivotal Study Completes Enrollment
SOUTH JORDAN, Utah, Aug. 03, 2023 (GLOBE NEWSWIRE) — Merit Medical Systems, Inc. (NASDAQ: MMSI), a leading global manufacturer and marketer of healthcare technology, today announced the completion of enrollment in its WRAPSODY Arteriovenous Access Efficacy (WAVE) pivotal study. Merit’s WAVE study is a prospective, randomized, controlled, multicenter study comparing the Merit WRAPSODY Cell-Impermeable Endoprosthesis […]
Alucent Biomedical Wins FDA Approval for U.S. Clinical Study
U.S. FDA Grants an Investigational Device Exemption for Trial Evaluating Novel AlucentNVS Technology
Quansys Biosciences and The Michael J. Fox Foundation Partner to Accelerate Parkinson’s Disease Research
Quansys Biosciences and The Michael J. Fox Foundation, announced a strategic partnership to accelerate research into PD.
Myriad Genetics Announces Inclusion of Breast Density to MyRisk® with RiskScore® Breast Cancer Risk Assessment
RiskScore is the first validated risk model that includes breast density, personal/family history and genetic markers. This comprehensive model is expected to identify more patients that could benefit from a change in their breast care.
BD Receives FDA 510(k) Clearance for Updated BD Alaris™ Infusion System
BD Alaris™ Infusion System is the only modular and most comprehensive infusion system on the U.S. market that includes large volume pumps, syringe pumps, patient-controlled analgesia (PCA) pumps, respiratory monitoring, auto-identification, dose error reduction software and EMR interoperability BD Alaris™ Infusion System’s unique “One System” platform securely connects all patient modules to provide care teams […]
Renalytix Announces Middle East Distribution Agreement with Vector Pharma
Distribution agreement opens kidneyintelX.dkd testing to address early-stage kidney disease in region with one of the highest incidence rates for type 2 diabetes globally
CancerVAX Reports Significant Progress on Universal Cancer Vaccine Development at UCLA
Three separate teams of physician scientists at UCLA working on three different parts of the project have made significant progress and are ready to merge their work into a complete proof-of-concept vaccine construct
Ultradent Adds New Cordless Prophy Handpiece
Ultradent Products, Inc. is announcing the addition of the Ultrapro™ Tx Cordless handpiece to its prestigious Ultrapro™ Tx prophylaxis family
CLENE ANNOUNCES PUBLICATION OF PHASE 2 CNM-AU8® CLINICAL DATA FOR THE TREATMENT OF ALS IN LANCET’S ECLINICALMEDICINE
Peer-reviewed publication includes data from the CNM-Au8 Phase 2 RESCUE-ALS trial and its open-label-extension, up to 120 weeks of patient follow-up
Recursion Celebrates Opening of Its Canadian Headquarters in Toronto with Government Officials and the Biotech Ecosystem
Recursion Celebrates Opening of Its Canadian Headquarters in Toronto with Government Officials and the Biotech Ecosystem
